바이오헤이븐 주식회사
US ˙ NYSE ˙ VGG1110E1079

SecurityBHVN / Biohaven Ltd.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership156,743 shares
Latest Disclosed Value $ 2,211,643
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 7.09% increase in ownership of BHVN / Biohaven Ltd.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 156,743 shares of Biohaven Ltd. (US:BHVN) valued at $2,211,644 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 146,372 shares of Biohaven Ltd.. This represents a change in shares of 7.09% during the quarter. The current value of the position is $1,692,824 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Biohaven EC VGG1110E1079 156,743 10,371 7.09 2,212 -37.15 0.0497
2025-05-28 2025-03-31 NP Biohaven EC VGG1110E1079 146,372 1,554 1.07 3,519 -34.95 0.0844
2025-02-25 2024-12-31 NP Biohaven EC VGG1110E1079 144,818 -2,548 -1.73 5,409 -26.55 0.1181
2024-11-26 2024-09-30 NP Biohaven EC VGG1110E1079 147,366 17,216 13.23 7,364 63.01 0.1393
2024-08-26 2024-06-30 NP Biohaven EC VGG1110E1079 130,150 10,245 8.54 4,518 -31.11 0.0920
2024-05-28 2024-03-31 NP Biohaven EC VGG1110E1079 119,905 -4,254 -3.43 6,558 23.39 0.1368
2024-02-26 2023-12-31 NP Biohaven EC VGG1110E1079 124,159 25,342 25.65 5,314 106.77 0.1134
2023-11-28 2023-09-30 NP Biohaven EC VGG1110E1079 98,817 -2,553 -2.52 2,570 6.02 0.0671
2023-08-25 2023-06-30 NP Biohaven EC VGG1110E1079 101,370 345 0.34 2,425 75.65 0.0575
2023-05-26 2023-03-31 NP Biohaven EC VGG1110E1079 101,025 5,663 5.94 1,380 4.31 0.0367
2023-02-24 2022-12-31 NP Biohaven EC VGG1110E1079 95,362 -5,978 -5.90 1,324 -91.36 0.0364
2022-11-25 2022-09-30 NP Biohaven Pharmaceutical Holding EC VGG111961055 101,340 4,665 4.83 15,320 8.75 0.4389
2022-08-25 2022-06-30 NP Biohaven Pharmaceutical Holding EC VGG111961055 96,675 11,095 12.96 14,087 38.82 0.3890
2022-05-26 2022-03-31 NP Biohaven Pharmaceutical Holding EC VGG111961055 85,580 261 0.31 10,147 -13.69 0.2364
2022-02-25 2021-12-31 NP Biohaven Pharmaceutical Holding EC VGG111961055 85,319 485 0.57 11,758 -0.23 0.2550
2021-11-24 2021-09-30 NP Biohaven Pharmaceutical Holding EC VGG111961055 84,834 3,176 3.89 11,784 48.66 0.2596
2021-08-26 2021-06-30 NP Biohaven Pharmaceutical Holding EC VGG111961055 81,658 8,488 11.60 7,927 58.51 0.1701
2021-05-27 2021-03-31 NP Biohaven Pharmaceutical Holding EC VGG111961055 73,170 -2,659 -3.51 5,001 -23.05 0.1134
2021-02-25 2020-12-31 NP Biohaven Pharmaceutical Holding EC VGG111961055 75,829 -2,358 -3.02 6,499 27.88 0.1665
2020-11-25 2020-09-30 NP Biohaven Pharmaceutical Holding EC VGG111961055 78,187 -1,516 -1.90 5,083 -12.79 0.1631
2020-08-27 2020-06-30 NP Biohaven Pharmaceutical Holding EC VGG111961055 79,703 8,082 11.28 5,827 139.11 0.1905
2020-06-01 2020-03-31 NP Biohaven Pharmaceutical Holding EC VGG111961055 71,621 11,808 19.74 2,437 -2.32 0.0996
2019-11-27 2019-09-30 NP Biohaven Pharmaceutical Holding EC VGG111961055 59,813 59,813 2,495 0.0825
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.